Key facts
- Notable investors include 8VC, Abstract Ventures, CancerX (USA).
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for LIND AI
- ·The full record, as it builds
Funding rounds
No funding rounds for LIND AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LIND AI
Developer of an eligibility assessment system intended to revolutionize healthcare by leveraging AI to unlock the potential of clinical data. The company offers treatment options to every patient, and the team is committed to harnessing the power of technology to match patients and providers with personalized and comprehensive treatment, enabling patients and medical professionals to identify active clinical trials for diseases from cancer to diabetes.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2023
- Employees
- 9
- Website
- lind.care/
- Ownership
- Privately Held (backing)
LIND AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LIND AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LIND AI in its N-PORT filings yet. We sweep new filings monthly.